Morphologic Correlations with Homologous Recombination Deficiency in BRCA1/2-Mutated and Non-BRCA-Mutated High-Grade Serous Carcinomas

被引：0
|
作者：
Chapagain, Udita [1 ]
Sun, Lulu [2 ]
机构：
[1] Washington Univ St Louis, St Louis, MO USA
[2] Washington Univ, Sch Med, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
895
引用
收藏
页码：S1121 / S1122
页数：2
相关论文
共 50 条
  • [21] Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
    Launonen, Inga-Maria P.
    Lyytikainen, Nuppu
    Casado, Julia
    Anttila, Ella A.
    Jacobson, Connor A.
    Lin, Jia R.
    Maliga, Zoltan
    Santaga, Sandro
    Elias, Kevin M.
    D'Andrea, Alan D.
    Konstantinopoulos, Panagiotis A.
    Sorger, Peter K.
    Farkkila, Anniina
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
    Ewing, Ailith
    Meynert, Alison
    Churchman, Michael
    Grimes, Graeme R.
    Hollis, Robert L.
    Herrington, C. Simon
    Rye, Tzyvia
    Bartos, Clare
    Croy, Ian
    Ferguson, Michelle
    Lennie, Mairi
    McGoldrick, Trevor
    McPhail, Neil
    Siddiqui, Nadeem
    Dowson, Suzanne
    Glasspool, Rosalind
    Mackean, Melanie
    Nussey, Fiona
    McDade, Brian
    Ennis, Darren
    McMahon, Lynn
    Matakidou, Athena
    Dougherty, Brian
    March, Ruth
    Barrett, J. Carl
    McNeish, Iain A.
    Biankin, Andrew, V
    Roxburgh, Patricia
    Gourley, Charlie
    Semple, Colin A.
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3201 - 3214
  • [23] Assessing difference in the tumor and immune microenvironment of BRCA1/2 mutated versus BRCA wild type high grade serous ovarian cancers
    Qian, Jing
    Roman, Lynda D.
    Rajpara, Seeta
    Neuman, Monica
    Khetan, Varun
    Craig, David W.
    Carlson, Joseph
    Carpten, John D.
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
    Kufel-Grabowska, Joanna
    Podolak, Amira
    Maliszewski, Daniel
    Bartoszkiewicz, Mikolaj
    Ramlau, Rodryg
    Lukaszuk, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [25] Role of BRCA1 promotor methylation (BRCA1meth) in homologous recombination deficiency (HRD) in high-grade epithelial ovarian cancer.
    Zeimet, Alain G.
    Schnaiter, Simon
    Reimer, Daniel Uwe
    Wimmer, Katharina
    Schamschula, Esther
    Leitner, Katharina
    Steger, Katharina
    Marth, Christian
    Fiegl, Heidi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer
    Fiegl, Heidelinde
    Schnaiter, Simon
    Reimer, Daniel U.
    Leitner, Katharina
    Nardelli, Petra
    Tsibulak, Irina
    Wieser, Verena
    Wimmer, Katharina
    Schamschula, Esther
    Marth, Christian
    Zeimet, Alain G.
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [27] Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas
    Kramer, C. J. H.
    Lanjouw, L.
    Ruano, D.
    ter Elst, A.
    Santandrea, G.
    Solleveld-Westerink, N.
    Werner, N.
    van Der Hout, A. H.
    de Kroon, C. D.
    van Wezel, T.
    Berger, L. P., V
    Jalving, M.
    Wesseling, J.
    Smit, V. T. H. B. M.
    de Bock, G. H.
    van Asperen, C. J.
    Mourits, M. J. E.
    Vreeswijk, M. P. G.
    Bart, J.
    Bosse, T.
    JOURNAL OF PATHOLOGY, 2024, 262 (02): : 137 - 146
  • [28] Use of PARP Inhibitors in BRCA1/2-mutated Pancreatic Carcinoma in Reality: a retrospective Analysis
    Zhang, D.
    Amin, S.
    Li, W.
    Joo, S.
    Adeboyeje, G.
    DeArbeloa, P.
    Petricoin, E. F.
    Blais, E. M.
    Pishvaian, M. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 225 - 225
  • [29] A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma
    Dong, Fei
    Davineni, Phani K.
    Howitt, Brooke E.
    Beck, Andrew H.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (11) : 1511 - 1516
  • [30] MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
    Lee, Cheng-Han
    Subramanian, Subbaya
    Beck, Andrew H.
    Espinosa, Inigo
    Senz, Janine
    Zhu, Shirley X.
    Huntsman, David
    van de Rijn, Matt
    Gilks, C. Blake
    PLOS ONE, 2009, 4 (10):
12345